Breast Cancer - HER2 Positive Clinical Trials

A listing of Breast Cancer - HER2 Positive medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Mobile Alabama 36608

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Arizona

Chandler Arizona 85224

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Gilbert Arizona 85234

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Glendale Arizona 85308

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Goodyear Arizona 85338

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Goodyear Arizona 85338

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

California

Anaheim California 92801

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Bakersfield California 93309

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Burbank California 91505

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

UPDATED

Fullerton California 92835

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

View More ▼

Long Beach California 90806

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Los Angeles California 90095

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

UPDATED

Los Angeles California 90033

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

UPDATED

Los Angeles California 90024

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

UPDATED

Los Angeles California 90017

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

UPDATED

Redondo Beach California 90277

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

UPDATED

Redondo Beach California 90277

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Sacramento California 95817

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

San Diego California 92123

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

San Francisco California 94115

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

San Francisco California 94115

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

UPDATED

Santa Maria California 93454

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

UPDATED

Santa Monica California 93454

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Stanford California 94305

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Vallejo California 94589

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Vallejo California 94589

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Colorado

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

UPDATED

Englewood Colorado 80112

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Fort Collins Colorado 80528

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Connecticut

Bridgeport Connecticut 06610

Patients are needed to participate in a clinical research study of Rapamycin and Trastuzumab to evaluate Breast Cancer

UPDATED

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

New Haven Connecticut 06519

Patients are needed to participate in a clinical research study of Rapamycin and Trastuzumab to evaluate Breast Cancer

UPDATED

Stamford Connecticut 06904

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

District of Columbia

Washington District of Columbia 20010

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Washington District of Columbia 20057

Patients are needed to participate in a clinical research study evaluating Trastuzumab, Pertuzumab, Ado-trastuzumab emtansine for the treatment of HER2 Positive Breast Cancer or Left Ventricular Function Systolic Dysfunction

Washington District of Columbia 20010

Patients are needed to participate in a clinical research study evaluating Trastuzumab, Pertuzumab, Ado-trastuzumab emtansine for the treatment of HER2 Positive Breast Cancer or Left Ventricular Function Systolic Dysfunction

UPDATED

Washington District of Columbia 20057

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Florida

Fort Myers Florida 33916

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Fort Myers Florida 33908

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

UPDATED

Fort Myers Florida 33901

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

UPDATED

Fort Myers Florida 33916

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Hollywood Florida 33021

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

View More ▼

UPDATED

Hollywood Florida 33021

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

UPDATED

Miami Florida 33176

Patients are needed to participate in a clinical research study evaluating DS-8201a for the treatment of Breast Cancer

Miami Beach Florida 33140

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

UPDATED

Miami Beach Florida 33140

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer